Biocatalist, LLC

Biocatalist is a biotechnology company that has developed a patented process using recombinant DNA technology for the manufacturing of peptides and peptide libraries. The company's platform engineers proteins containing repeated units of specific peptides, which are then expressed in host organisms and purified. This approach provides a sustainable alternative to traditional chemical synthesis, which is known to generate significant amounts of toxic waste. By enabling the biological production of shorter natural peptides, the technology is designed to reduce manufacturing costs by at least five-fold, decrease energy consumption, and shrink required bioreactor sizes by up to 10-fold.

The company’s solutions support ESG objectives for manufacturers in industries such as pharmaceuticals, medicine, and agriculture, including the production of peptide hormones, cancer vaccines, antimicrobial peptides, and bio-pesticides. Biocatalist offers custom services for peptide and peptide library production, as well as specialized mass spectrometry calibration standards. These offerings are designed to help customers improve production efficiency, reduce environmental impact, and achieve greater accuracy in analytical applications. Located in Torrance, California, the company emphasizes the intersection of technical innovation and environmental responsibility in its product and service delivery.